|
1994 Journal Article Prediction of Survival in a Hospital-Based Continuing Care UnitHardy, JR, Turner, R, Saunders, M and Ahern, R (1994). Prediction of Survival in a Hospital-Based Continuing Care Unit. European Journal of Cancer, 30A (3), 284-288. doi: 10.1016/0959-8049(94)90242-9 |
|
1992 Journal Article A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-CancerObrien, Mer, Hardy, J, Tan, S, Walling, J, Peters, B, Hatty, S and Wiltshaw, E (1992). A Phase-Ii Study of Sulofenur, a Novel Sulfonylurea, in Recurrent Epithelial Ovarian-Cancer. Cancer Chemotherapy and Pharmacology, 30 (3), 245-248. doi: 10.1007/BF00686324 |
|
1991 Journal Article Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-CancerHarvey, VJ, Hardy, JR, Smith, S, Grove, W and Baguley, BC (1991). Phase II Study of the Amsacrine Analog Ci-921 (nsc 343499) in Non-Small-Cell Lung-Cancer. European Journal of Cancer, 27 (12), 1617-1620. doi: 10.1016/0277-5379(91)90427-F |
|
1991 Journal Article Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 CasesFossella, FV, Lippman, SM, Seitz, DE, Alberts, DS, Taylor, CW, Wiltshaw, E, Hardy, J, Obrien, M, Haynes, TR and Wolen, RL (1991). Hypoprothrombinemia From Coadministration of Sulofenur (ly-186641) and Warfarin - Report of 3 Cases. Investigational New Drugs, 9 (4), 357-359. |
|
1991 Journal Article Lymphedema - Prevention Rather Than CureHardy, JR (1991). Lymphedema - Prevention Rather Than Cure. Annals of Oncology, 2 (8), 532-533. doi: 10.1093/oxfordjournals.annonc.a058015 |
|
1991 Journal Article A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancerPowles, T. J., Jones, A. L., Judson, I. R., Hardy, J. R. and Ashley, S. E. (1991). A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. British Journal of Cancer, 64 (2), 406-410. doi: 10.1038/bjc.1991.318 |
|
1991 Journal Article The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer PatientsNewell, DR, Mansi, J, Hardy, J, Button, D, Jenns, K, Smith, IE, Picollo, R and Catanese, B (1991). The Pharmacokinetics of Oral Lonidamine in Breast and Lung-Cancer Patients. Seminars in Oncology, 18 (2), 11-17. |
|
1991 Journal Article Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-CarcinomaHardy, JR, Wiltshaw, E, Blake, PR, Harper, P, Slevin, M, Perren, TJ and Tan, S (1991). Cisplatin and Carboplatin in Combination for the Treatment of Stage-Iv Ovarian-Carcinoma. Annals of Oncology, 2 (2), 131-136. doi: 10.1093/oxfordjournals.annonc.a057876 |
|
1991 Journal Article Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-CancerJones, AL, Hardy, JR, Newell, DR and Smith, IE (1991). Clinical-Study and Pharmacokinetics of Lonidamine in Advanced Non-Small Cell Lung-Cancer. European Journal of Cancer, 27 (4), 519-519. doi: 10.1016/0277-5379(91)90403-Z |
|
1990 Journal Article Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancerJones, A. L., Williams, M. P., Powles, T. J., Oliff, J. F. C., Hardy, J. R., Cherryman, G. and Husband, J. (1990). Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer. British Journal of Cancer, 62 (2), 296-298. doi: 10.1038/bjc.1990.281 |
|
1990 Journal Article Carboplatin Dose OptimizationPinkerton, C. R. and Hardy, J. R. (1990). Carboplatin Dose Optimization. Journal of Clinical Oncology, 8 (7), 1283-1284. doi: 10.1200/JCO.1990.8.7.1283 |
|
1990 Journal Article How nephrotoxic is carboplatin?Hardy, J. R., Tan, S., Fryatt, I. and Wiltshaw, E. (1990). How nephrotoxic is carboplatin?. British Journal of Cancer, 61 (4), 644-644. doi: 10.1038/bjc.1990.143 |
|
1990 Journal Article Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-CancerHardy, JR, Powles, TJ, Judson, IR, Sinnett, HD, Ashley, SE, Coombes, RC and Ellin, CL (1990). Combination of Tamoxifen, Aminoglutethimide, Danazol and Medroxyprogesterone Acetate in Advanced Breast-Cancer. European Journal of Cancer, 26 (7), 824-827. doi: 10.1016/0277-5379(90)90162-M |
|
1989 Journal Article Case-Report - Magnetic-Resonance Imaging of Spinal AmyloidOlliff, Jfc, Hardy, JR, Williams, MP and Powles, TJ (1989). Case-Report - Magnetic-Resonance Imaging of Spinal Amyloid. Clinical Radiology, 40 (6), 632-633. doi: 10.1016/S0009-9260(89)80329-0 |
|
1989 Journal Article Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancerHardy, J. R., Noble, T. and Smith, I. E. (1989). Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer. British Journal of Cancer, 60 (5), 764-766. doi: 10.1038/bjc.1989.355 |
|
1989 Journal Article Chemoprevention of Breast-CancerPowles, TJ, Hardy, JR, Ashley, SE, Cosgrove, D, Davey, JB, Dowsett, M, McKinna, A, Nash, AG, Rundle, SK, Sinnett, HD, Tillyer, CR and Treleaven, JG (1989). Chemoprevention of Breast-Cancer. Breast Cancer Research and Treatment, 14 (1), 23-31. doi: 10.1007/BF01805972 |
|
1989 Journal Article A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerPowles, T. J., Hardy, J. R., Ashley, S. E., Farrington, G. M., Cosgrove, D., Davey, J. B., Dowsett, M., McKinna, J. A., Nash, A. G., Sinnett, H. D., Tillyer, C. R. and Treleaven, J. G. (1989). A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. British Journal of Cancer, 60 (1), 126-131. doi: 10.1038/bjc.1989.235 |
|
1989 Journal Article Cerebral Metastases in Patients with Ovarian-Cancer Treated with ChemotherapyHardy, JR and Harvey, VJ (1989). Cerebral Metastases in Patients with Ovarian-Cancer Treated with Chemotherapy. Gynecologic Oncology, 33 (3), 296-300. doi: 10.1016/0090-8258(89)90515-5 |
|
1989 Journal Article The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the RabbitPaxton, JW, Evans, PC and Hardy, JR (1989). The Effect of Cimetidine, Phenobarbitone and Buthionine Sulfoximine On the Disposition of N-5-Dimethyl-9-[(2-Methoxy-4-Methyl-Sulphonylamino) Phenylamino]-4-Acridinecarboxamide (ci-921) in the Rabbit. Cancer Chemotherapy and Pharmacology, 23 (5), 291-295. doi: 10.1007/BF00292406 |
|
1988 Journal Article Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921)Hardy, JR, Harvey, VJ, Paxton, JW, Evans, P, Smith, S, Grove, W, Grillolopez, AJ and Baguley, BC (1988). Phase-I Trial of the Amsacrine Analog 9-((2-Methoxy-4-[(methylsulfonyl)amino]-Phenyl(amino)-N,5-Dimethyl-4-Acridinecarboxamide (ci-921). Cancer Research, 48 (22), 6593-6596. |
